Back
Finch Therapeutics Group Stock Price Chart
Sell
10
FNCH
Finch Therapeutics Group
Last Price:
2.02
Seasonality Move:
-2.43%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FNCH is experiencing selling pressure, which indicates risk of future bearish movement.
Finch Therapeutics Group Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.99 | Sell |
20-day SMA: | 2.2 | Sell |
50-day SMA: | 2.41 | Sell |
200-day SMA: | 3.79 | Sell |
8-day EMA: | 2.02 | Sell |
20-day EMA: | 2.15 | Sell |
50-day EMA: | 2.36 | Sell |
200-day EMA: | 6.67 | Sell |
Finch Therapeutics Group Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 42.23 | Sell |
Chaikin Money Flow: | -6468 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2 - 2.52) | Sell |
Bollinger Bands (100): | (2.21 - 3.07) | Sell |
Finch Therapeutics Group Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Finch Therapeutics Group Stock
Is Finch Therapeutics Group Stock a Buy?
- Finch Therapeutics Group share price is 1.94 while FNCH 8-day simple moving average is 1.99, which is a Sell signal.
- The stock price of FNCH is 1.94 while Finch Therapeutics Group 20-day SMA is 2.20, which makes it a Sell.
- Finch Therapeutics Group 50-day simple moving average is 2.41 while FNCH share price is 1.94, making it a Sell technically.
- FNCH stock price is 1.94 and Finch Therapeutics Group 200-day simple moving average is 3.79, creating a Sell signal.
FNCH Technical Analysis vs Fundamental Analysis
Sell
10
Finch Therapeutics Group (FNCH)
is a Sell
Is Finch Therapeutics Group a Buy or a Sell?
-
Finch Therapeutics Group stock is rated a Sell
The current Finch Therapeutics Group [FNCH] share price is $1.94. The Score for FNCH is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
Finch Therapeutics Group Stock Info
Market Cap:
3.12M
Price in USD:
1.94
Share Volume:
9.29K
Finch Therapeutics Group 52-Week Range
52-Week High:
16.74
52-Week Low:
1.86
Sell
10
Finch Therapeutics Group (FNCH)
is a Sell
Finch Therapeutics Group Share Price Forecast
-
What is the Finch Therapeutics Group stock price today?
The Finch Therapeutics Group stock price is 1.94 USD today. -
Will FNCH stock go up or go down?
Finch Therapeutics Group> share price is forecast to RISE/FALL based on technical indicators -
Is Finch Therapeutics Group overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Finch Therapeutics Group is overvalued.
Is Finch Therapeutics Group Stock a Buy?
- Finch Therapeutics Group share price is 1.94 while FNCH 8-day exponential moving average is 2.02, which is a Sell signal.
- The stock price of FNCH is 1.94 while Finch Therapeutics Group 20-day EMA is 2.15, which makes it a Sell.
- Finch Therapeutics Group 50-day exponential moving average is 2.36 while FNCH share price is 1.94, making it a Sell technically.
- FNCH stock price is 1.94 and Finch Therapeutics Group 200-day simple moving average is 6.67, creating a Sell signal.
Fundamental Analysis of Finch Therapeutics Group
Is Finch Therapeutics Group a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $29.13 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Finch Therapeutics Group
Should I short Finch Therapeutics Group stock?
- FNCH Moving Average Covergence Divergence (MACD) indicator is -0.13, suggesting Finch Therapeutics Group is a Sell
- Finch Therapeutics Group Relative Strength Index (RSI) is 42.23, which suggest Finch Therapeutics Group is oversold
- The Bollinger Bands (25) for Finch Therapeutics Group is (2 - 2.52), which suggest Finch Therapeutics Group is a Sell
- The Bollinger Bands (100) for Finch Therapeutics Group is (2.21 - 3.07), which suggest Finch Therapeutics Group is a Sell
* Finch Therapeutics Group stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.